New search Show text from Guidelines
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTSL01 ANTINEOPLASTIC AGENTS
L01X OTHER ANTINEOPLASTIC AGENTS
L01XC Monoclonal antibodies
| ATC code | Name | DDD | U | Adm.R | Note |
| L01XC01 | edrecolomab | ||||
| L01XC02 | rituximab | ||||
| L01XC03 | trastuzumab | ||||
| L01XC05 | gemtuzumab ozogamicin | ||||
| L01XC06 | cetuximab | ||||
| L01XC07 | bevacizumab | ||||
| L01XC08 | panitumumab | ||||
| L01XC09 | catumaxomab | ||||
| L01XC10 | ofatumumab | ||||
| L01XC11 | ipilimumab | ||||
| L01XC12 | brentuximab vedotin | ||||
| L01XC13 | pertuzumab | ||||
| L01XC14 | trastuzumab emtansine | ||||
| L01XC15 | obinutuzumab | ||||
| L01XC16 | dinutuximab beta | ||||
| L01XC17 | nivolumab | ||||
| L01XC18 | pembrolizumab | ||||
| L01XC19 | blinatumomab | ||||
| L01XC21 | ramucirumab | ||||
| L01XC22 | necitumumab | ||||
| L01XC23 | elotuzumab | ||||
| L01XC24 | daratumumab | ||||
| L01XC25 | mogamulizumab | ||||
| L01XC26 | inotuzumab ozogamicin | ||||
| L01XC27 | olaratumab | ||||
| L01XC28 | durvalumab | ||||
| L01XC29 | bermekimab | ||||
| L01XC31 | avelumab | ||||
| L01XC32 | atezolizumab |
Last updated: 2018-12-13